TCVAX Fees and Costs — Touchstone Mid Cap Value Fund, Class A
Data updated: 2026-08-26
The net expense ratio is 1.17%: a 0.64% management fee, a 0.25% 12b-1 fee plus 0.47% other expenses, less a 0.19% fee waiver. This share class carries a maximum front-end sales load of 5.00%. In fiscal 2024 the fund paid $176K in broker commissions, 0.0242% of average net assets, and portfolio turnover was 32%.
TCVAX Fees and Expenses
Annual operating expenses and sales charges of TCVAX. Prospectus, as of September 30, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.64% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.47% |
| Gross expense ratio | 1.36% |
| Fee waiver | −0.19% |
| Net expense ratio | 1.17% |
| Sales charges | |
|---|---|
| Max front load | 5.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
TCVAX Costs Over Time
On $10,000 invested in TCVAX, assuming 5% a year before costs, total costs come to $1,345 over 5 years, cutting the return by 2.31% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $500 | $500 | $500 |
| Fund expenses (net expense ratio 1.17%) | $117 | $363 | $629 |
| Trading costs (broker commissions) | $2 | $8 | $13 |
| Lost growth on money paid in costs | $25 | $97 | $203 |
| Total costs | $644 | $968 | $1,345 |
| Value after costs | $9,856 | $10,608 | $11,418 |
| Impact on return, per year | 6.44% | 3.01% | 2.31% |
TCVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.0242%
- Total broker commissions: $176K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 32%
- Securities on loan, average value: $1.9M
- Net income from securities lending: $8K (0.001% of average net assets)
TCVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Jefferies LLC | $36K | 21.91% |
| Piper Sandler & Co. | $28K | 16.97% |
| Robert W. Baird & Co. Incorporated | $28K | 16.92% |
| Keefe, Bruyette & Woods, Inc. | $18K | 11.00% |
| Truist Securities, Inc. | $15K | 9.16% |
| KeyBanc Capital Markets Inc. | $9K | 5.58% |
| Wells Fargo Securities, LLC | $8K | 5.08% |
| Goldman Sachs & Co. LLC | $8K | 4.78% |
| Stifel, Nicolaus & Company, Incorporated | $7K | 4.34% |
| Luminex Trading & Analytics LLC | $7K | 4.26% |
Touchstone Mid Cap Value Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| TCVIX | Institutional Class | 0.84% | none |
| TCVYX | Class Y | 0.93% | none |
| TCVAX | Class A | 1.17% | 5.00% |
| TMFCX | Class C | 1.92% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.